Noticias/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitivMenos de 1 minuto de lecturaCVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. Acciones alemanasAcciones británicasAcciones estadounidensesEuropaInformes financierosReuters© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlMostrar másInicie sesión o cree una cuenta gratuita y permanente para leer esta noticia¡Vamos allá!
